These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 173178)

  • 1. Staging in the therapy of cancer of the breast.
    Silverberg SG
    Am J Clin Pathol; 1975 Dec; 64(6):756-63. PubMed ID: 173178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes.
    Hunter RL; Ferguson DJ; Coppleson LW
    Cancer; 1975 Aug; 36(2):528-39. PubMed ID: 168957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive ductal carcinoma of the breast with a predominant intraductal component: cooperative clinicopathologic study in seven Japanese centers.
    Enjoji M; Matsukuma A; Sakamoto G; Toyoshima S; Hirota T; Wada A; Ishida T; Enomoto K; Koyama H; Yamamoto H
    Jpn J Clin Oncol; 1992 Apr; 22(2):84-91. PubMed ID: 1320141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.
    Fisher ER; Gregorio R; Redmond C; Dekker A; Fisher B
    Am J Clin Pathol; 1976 Jan; 65(1):21-30. PubMed ID: 174420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
    Dawson PJ; Ferguson DJ; Karrison T
    Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast.
    Silverberg SG; Chitale AR
    Cancer; 1973 Oct; 32(4):830-7. PubMed ID: 4356480
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal breast cancers: histological and immunohistological findings].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1985; 69():331-7. PubMed ID: 3006384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Micrometastases in axillary lymph nodes in breast cancer].
    Ronay G; Tomesch A; Tulusan AH
    Gynakol Rundsch; 1989; 29 Suppl 2():234-6. PubMed ID: 2558989
    [No Abstract]   [Full Text] [Related]  

  • 12. Ductal Carcinoma In Situ Simultaneously Involving the Breast and Epithelial Inclusions in an Ipsilateral Axillary Lymph Node.
    Commander LA; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
    Int J Surg Pathol; 2018 Sep; 26(6):564-568. PubMed ID: 29560779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TNM and grading as prognostic factors in breast cancer].
    Ibáñez T; Bilbao J; Toledo JD
    Pathologe; 1993 May; 14(3):144-9. PubMed ID: 8390656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signet ring cell histiocytosis in axillary lymph nodes: a sheep in wolves' clothing? A potentially under-recognized pitfall in the diagnosis of metastatic breast cancer.
    Pathi R; Lawrence WD; Barroeta JE
    Breast J; 2009; 15(3):302-3. PubMed ID: 19645788
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ arising in an epithelial inclusion within an axillary lymph node.
    Srinivasan B; Allan CP; Armes JE
    Pathology; 2007 Apr; 39(2):268-9. PubMed ID: 17454760
    [No Abstract]   [Full Text] [Related]  

  • 20. Infiltrating ductal carcinoma of the breast in South Australia. Sizes of primary lesions and histological evidence of axillary nodal metastases.
    Bonett A; Roder D; Esterman A
    Med J Aust; 1983 Jul; 2(1):26-8. PubMed ID: 6306416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.